Bruno Fuchs

2.9k total citations
64 papers, 2.2k citations indexed

About

Bruno Fuchs is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Bruno Fuchs has authored 64 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 28 papers in Pulmonary and Respiratory Medicine and 17 papers in Cancer Research. Recurrent topics in Bruno Fuchs's work include Sarcoma Diagnosis and Treatment (23 papers), Bone Tumor Diagnosis and Treatments (8 papers) and Cell Adhesion Molecules Research (8 papers). Bruno Fuchs is often cited by papers focused on Sarcoma Diagnosis and Treatment (23 papers), Bone Tumor Diagnosis and Treatments (8 papers) and Cell Adhesion Molecules Research (8 papers). Bruno Fuchs collaborates with scholars based in Switzerland, United States and Germany. Bruno Fuchs's co-authors include Walter Born, Roman Muff, Felix Regenfelder, Silvia Schmutz, Matthias Arlt, Robert Hudek, Peter P. Koch, Aleksandar Boro, Carrie Y. Inwards and Ralf Janknecht and has published in prestigious journals such as PLoS ONE, Cancer and Cancer Research.

In The Last Decade

Bruno Fuchs

64 papers receiving 2.2k citations

Peers

Bruno Fuchs
David Lagares United States
Bruno Fuchs
Citations per year, relative to Bruno Fuchs Bruno Fuchs (= 1×) peers David Lagares

Countries citing papers authored by Bruno Fuchs

Since Specialization
Citations

This map shows the geographic impact of Bruno Fuchs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Fuchs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Fuchs more than expected).

Fields of papers citing papers by Bruno Fuchs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Fuchs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Fuchs. The network helps show where Bruno Fuchs may publish in the future.

Co-authorship network of co-authors of Bruno Fuchs

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Fuchs. A scholar is included among the top collaborators of Bruno Fuchs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Fuchs. Bruno Fuchs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ameline, Baptiste, Silvia Höfer, Bruno Fuchs, et al.. (2022). Metastatic mesenchymal chondrosarcoma showing a sustained response to cabozantinib: A case report. Frontiers in Oncology. 12. 1086677–1086677. 5 indexed citations
2.
Boro, Aleksandar, Matthias Arlt, Barbara Niederöst, et al.. (2020). Exploring the Role of Osteosarcoma-Derived Extracellular Vesicles in Pre-Metastatic Niche Formation and Metastasis in the 143-B Xenograft Mouse Osteosarcoma Model. Cancers. 12(11). 3457–3457. 33 indexed citations
3.
Arlt, Matthias, et al.. (2019). Fascin-1 enhances experimental osteosarcoma tumor formation and metastasis and is related to poor patient outcome. BMC Cancer. 19(1). 83–83. 24 indexed citations
4.
Robl, Bernhard, et al.. (2016). Evaluation of intraarterial and intravenous cisplatin chemotherapy in the treatment of metastatic osteosarcoma using an orthotopic xenograft mouse model. Journal of Experimental & Clinical Cancer Research. 35(1). 113–113. 13 indexed citations
5.
Cathomas, Richard, et al.. (2014). RANK Ligand Blockade with Denosumab in Combination with Sorafenib in Chemorefractory Osteosarcoma: A Possible Step Forward?. Oncology. 88(4). 257–260. 35 indexed citations
6.
Pauli, Chantal, Bruno Fuchs, Christian W. A. Pfirrmann, et al.. (2014). Response of an aggressive periosteal aneurysmal bone cyst (ABC) of the radius to denosumab therapy. World Journal of Surgical Oncology. 12(1). 17–17. 30 indexed citations
7.
Gvozdenovic, Ana, Matthias Arlt, Knut Husmann, et al.. (2013). Silencing of CD44 Gene Expression in Human 143-B Osteosarcoma Cells Promotes Metastasis of Intratibial Tumors in SCID Mice. PLoS ONE. 8(4). e60329–e60329. 21 indexed citations
8.
Husmann, Knut, Matthias Arlt, Roman Muff, et al.. (2012). Matrix Metalloproteinase 1 promotes tumor formation and lung metastasis in an intratibial injection osteosarcoma mouse model. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1832(2). 347–354. 40 indexed citations
9.
Arlt, Matthias, Walter Born, & Bruno Fuchs. (2012). Improved Visualization of Lung Metastases at Single Cell Resolution in Mice by Combined <em>In-situ</em> Perfusion of Lung Tissue and X-Gal Staining of <em>lacZ</em>-Tagged Tumor Cells. Journal of Visualized Experiments. e4162–e4162. 9 indexed citations
10.
Betz, Michael, Charles E. Dumont, Bruno Fuchs, & Ulrich Exner. (2011). Physeal Distraction for Joint Preservation in Malignant Metaphyseal Bone Tumors in Children. Clinical Orthopaedics and Related Research. 470(6). 1749–1754. 32 indexed citations
11.
Arlt, Matthias, In go J. Banke, Denise K. Walters, et al.. (2011). LacZ transgene expression in the subcutaneous Dunn/LM8 osteosarcoma mouse model allows for the identification of micrometastasis. Journal of Orthopaedic Research®. 29(6). 938–946. 31 indexed citations
12.
Steinmann, Patrick, Denise K. Walters, Matthias Arlt, et al.. (2011). Antimetastatic activity of honokiol in osteosarcoma. Cancer. 118(8). 2117–2127. 42 indexed citations
13.
Arlt, Matthias, Denise K. Walters, In go J. Banke, et al.. (2011). The antineoplastic antibiotic taurolidine promotes lung and liver metastasis in two syngeneic osteosarcoma mouse models and exhibits severe liver toxicity. International Journal of Cancer. 131(5). E804–12. 16 indexed citations
14.
Hudek, Robert, Silvia Schmutz, Felix Regenfelder, Bruno Fuchs, & Peter P. Koch. (2009). Novel Measurement Technique of the Tibial Slope on Conventional MRI. Clinical Orthopaedics and Related Research. 467(8). 2066–2072. 270 indexed citations
15.
Srivastava, Alok, Bruno Fuchs, Kunbo Zhang, et al.. (2006). High WT1 Expression Is Associated with Very Poor Survival of Patients with Osteogenic Sarcoma Metastasis. Clinical Cancer Research. 12(14). 4237–4243. 32 indexed citations
16.
Fuchs, Bruno, Carrie Y. Inwards, Sean P. Scully, & Ralf Janknecht. (2004). hTERT Is Highly Expressed in Ewing???s Sarcoma and Activated by EWS-ETS Oncoproteins. Clinical Orthopaedics and Related Research. 426(426). 64–68. 21 indexed citations
17.
Zhang, Kunbo, Norbert Dion, Bruno Fuchs, et al.. (2002). The human homolog of yeast SEP1 is a novel candidate tumor suppressor gene in osteogenic sarcoma. Gene. 298(2). 121–127. 19 indexed citations
18.
Fuchs, Bruno, Kunbo Zhang, Mark E. Bolander, & Gobinda Sarkar. (2000). Differential mRNA fingerprinting by preferential amplification of coding sequences. Gene. 258(1-2). 155–163. 10 indexed citations
19.
Fuchs, Bruno, Kunbo Zhang, Mark E. Bolander, & Gobinda Sarkar. (2000). Identification of Differentially Expressed Genes by Mutually Subtracted RNA Fingerprinting. Analytical Biochemistry. 286(1). 91–98. 18 indexed citations
20.
Fuchs, Bruno, Kunbo Zhang, Michael G. Rock, Mark E. Bolander, & Gobinda Sarkar. (1999). Repeat cDNA Synthesis and RT-PCR with the Same Source of RNA. Molecular Biotechnology. 12(3). 231–236. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026